Cargando…
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
The annual “Antibody Industrial Symposium”, co-organized by LabEx MAbImprove and MabDesign, held its 10th anniversary edition in Montpellier, France, on June 28–29, 2022. The meeting focused on new results and concepts in antibody engineering (naked, mono- or multi-specific, conjugated to drugs or r...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187075/ https://www.ncbi.nlm.nih.gov/pubmed/37184206 http://dx.doi.org/10.1080/19420862.2023.2211692 |
_version_ | 1785042680256921600 |
---|---|
author | Antunes, Ana Alvarez-Vallina, Luis Bertoglio, Federico Bouquin, Nicolas Cornen, Stéphanie Duffieux, Francis Ferré, Pierre Gillet, Raphaëlle Jorgensen, Christian Leick, Mark B Maillère, Bernard Negre, Hélène Pelegrin, Mireia Poirier, Nicolas Reusch, Dietmar Robert, Bruno Serre, Guy Vicari, Alain Villalba, Martin Volpers, Christoph Vuddamalay, Gavin Watier, Hervé Wurch, Thierry Zabeau, Lennart Zielonka, Stefan Zhang, Baolin Beck, Alain Martineau, Pierre |
author_facet | Antunes, Ana Alvarez-Vallina, Luis Bertoglio, Federico Bouquin, Nicolas Cornen, Stéphanie Duffieux, Francis Ferré, Pierre Gillet, Raphaëlle Jorgensen, Christian Leick, Mark B Maillère, Bernard Negre, Hélène Pelegrin, Mireia Poirier, Nicolas Reusch, Dietmar Robert, Bruno Serre, Guy Vicari, Alain Villalba, Martin Volpers, Christoph Vuddamalay, Gavin Watier, Hervé Wurch, Thierry Zabeau, Lennart Zielonka, Stefan Zhang, Baolin Beck, Alain Martineau, Pierre |
author_sort | Antunes, Ana |
collection | PubMed |
description | The annual “Antibody Industrial Symposium”, co-organized by LabEx MAbImprove and MabDesign, held its 10th anniversary edition in Montpellier, France, on June 28–29, 2022. The meeting focused on new results and concepts in antibody engineering (naked, mono- or multi-specific, conjugated to drugs or radioelements) and also on new cell-based therapies, such as chimeric antigenic receptor (CAR)-T cells. The symposium, which brought together scientists from academia and industry, also addressed issues concerning the production of these molecules and cells, and the necessary steps to ensure a strong intellectual property protection of these new molecules and approaches. These two days of exchanges allowed a rich discussion among the various actors in the field of therapeutic antibodies. |
format | Online Article Text |
id | pubmed-10187075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-101870752023-05-17 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies Antunes, Ana Alvarez-Vallina, Luis Bertoglio, Federico Bouquin, Nicolas Cornen, Stéphanie Duffieux, Francis Ferré, Pierre Gillet, Raphaëlle Jorgensen, Christian Leick, Mark B Maillère, Bernard Negre, Hélène Pelegrin, Mireia Poirier, Nicolas Reusch, Dietmar Robert, Bruno Serre, Guy Vicari, Alain Villalba, Martin Volpers, Christoph Vuddamalay, Gavin Watier, Hervé Wurch, Thierry Zabeau, Lennart Zielonka, Stefan Zhang, Baolin Beck, Alain Martineau, Pierre MAbs Meeting Report The annual “Antibody Industrial Symposium”, co-organized by LabEx MAbImprove and MabDesign, held its 10th anniversary edition in Montpellier, France, on June 28–29, 2022. The meeting focused on new results and concepts in antibody engineering (naked, mono- or multi-specific, conjugated to drugs or radioelements) and also on new cell-based therapies, such as chimeric antigenic receptor (CAR)-T cells. The symposium, which brought together scientists from academia and industry, also addressed issues concerning the production of these molecules and cells, and the necessary steps to ensure a strong intellectual property protection of these new molecules and approaches. These two days of exchanges allowed a rich discussion among the various actors in the field of therapeutic antibodies. Taylor & Francis 2023-05-15 /pmc/articles/PMC10187075/ /pubmed/37184206 http://dx.doi.org/10.1080/19420862.2023.2211692 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Meeting Report Antunes, Ana Alvarez-Vallina, Luis Bertoglio, Federico Bouquin, Nicolas Cornen, Stéphanie Duffieux, Francis Ferré, Pierre Gillet, Raphaëlle Jorgensen, Christian Leick, Mark B Maillère, Bernard Negre, Hélène Pelegrin, Mireia Poirier, Nicolas Reusch, Dietmar Robert, Bruno Serre, Guy Vicari, Alain Villalba, Martin Volpers, Christoph Vuddamalay, Gavin Watier, Hervé Wurch, Thierry Zabeau, Lennart Zielonka, Stefan Zhang, Baolin Beck, Alain Martineau, Pierre 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies |
title | 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies |
title_full | 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies |
title_fullStr | 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies |
title_full_unstemmed | 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies |
title_short | 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies |
title_sort | 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies |
topic | Meeting Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187075/ https://www.ncbi.nlm.nih.gov/pubmed/37184206 http://dx.doi.org/10.1080/19420862.2023.2211692 |
work_keys_str_mv | AT antunesana 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT alvarezvallinaluis 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT bertogliofederico 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT bouquinnicolas 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT cornenstephanie 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT duffieuxfrancis 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT ferrepierre 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT gilletraphaelle 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT jorgensenchristian 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT leickmarkb 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT maillerebernard 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT negrehelene 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT pelegrinmireia 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT poiriernicolas 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT reuschdietmar 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT robertbruno 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT serreguy 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT vicarialain 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT villalbamartin 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT volperschristoph 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT vuddamalaygavin 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT watierherve 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT wurchthierry 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT zabeaulennart 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT zielonkastefan 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT zhangbaolin 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT beckalain 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies AT martineaupierre 10thantibodyindustrialsymposiumnewdevelopmentsinantibodyandadoptivecelltherapies |